Trevi Therapeutics, Inc.TRVINASDAQ
Loading
SG&A Expenses Over TimeExpanding
Percentile Rank100
3Y CAGR+16.2%
5Y CAGR+9.3%
Year-over-Year Change
Selling, general, and administrative expenses
3Y CAGR
+16.2%/yr
vs +23.5%/yr prior
5Y CAGR
+9.3%/yr
Recent acceleration
Acceleration
-7.2pp
Decelerating
Percentile
P100
Near historical high
vs 5Y Ago
1.6x
Solid growth
Streak
4 yr
Consecutive growthExpanding
| Period | Value | YoY Change |
|---|---|---|
| TTM | $15.82M | +30.2% |
| 2024 | $12.15M | +18.6% |
| 2023 | $10.24M | +1.7% |
| 2022 | $10.07M | +6.1% |
| 2021 | $9.49M | -6.6% |
| 2020 | $10.16M | +39.1% |
| 2019 | $7.31M | +68.5% |
| 2018 | $4.34M | +102.4% |
| 2017 | $2.14M | +25.4% |
| 2016 | $1.71M | - |